Q32 Bio (QTTB) news

Q32 Bio Inc.: Wells Fargo cuts target price to $59 from $66

Q32 Bio Inc. (QTTB) has seen recent analyst activity, with Wells Fargo adjusting its price target for the stock. The firm reduced its target to $59 from $66, maintaining a "Buy" rating as of July 13, 2026. This adjustment reflects a revised outlook amid ongoing developments in the biotechnology…

Q32 Bio Inc.: H.C. Wainwright raises target price to $36 from $13

Q32 Bio - selling stockholders may offer up to 6.88 mln shares of common stock - SEC filing

Q32 Bio Inc. (Nasdaq: QTTB) has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) that allows selling stockholders to offer up to 6.88 million shares of its common stock, according to a recent SEC filing. The shares may be offered and sold from time to time in…

Q32 Bio - prices public offering of 6.03 mln shares at $18.25 per share

Q32 Bio Inc. (NASDAQ: QTTB) has priced a public offering of 6.03 million shares of its common stock at $18.25 per share, according to a recent announcement. The offering, which is part of a broader $200 million underwritten public offering, includes pre-funded warrants to purchase shares of common…

Q32 Bio prices $200M offering of stock and pre-funded warranties

Q32 Bio Inc. (Nasdaq: QTTB) has priced a $200 million public offering of common stock and pre-funded warrants, with the underwriters granted additional $30 million option . The offering, led by Morgan Stanley, Jefferies, Cantor, and Oppenheimer & Co., is intended to support the company’s research,…